Raymond James & Associates lifted its holdings in shares of Endava plc (NYSE:DAVA – Free Report) by 3.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 107,042 shares of the company’s stock after acquiring an additional 3,513 shares during the period. Raymond James & Associates owned 0.19% of Endava worth $2,734,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of DAVA. Blue Trust Inc. purchased a new position in shares of Endava in the 3rd quarter valued at approximately $30,000. Headlands Technologies LLC purchased a new position in Endava in the 1st quarter valued at $49,000. Seven Eight Capital LP acquired a new position in Endava in the 2nd quarter valued at $216,000. Sanctuary Advisors LLC purchased a new position in Endava during the 2nd quarter worth $263,000. Finally, Duality Advisers LP acquired a new stake in shares of Endava in the 1st quarter worth $284,000. 62.23% of the stock is owned by institutional investors and hedge funds.
Endava Stock Up 1.1 %
Endava stock opened at $23.97 on Tuesday. Endava plc has a fifty-two week low of $23.28 and a fifty-two week high of $81.06. The firm has a market capitalization of $1.38 billion, a price-to-earnings ratio of 66.58 and a beta of 1.21. The stock’s fifty day moving average is $27.42 and its two-hundred day moving average is $28.68. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.74 and a current ratio of 1.74.
Wall Street Analyst Weigh In
DAVA has been the topic of a number of recent analyst reports. Guggenheim dropped their price target on shares of Endava from $55.00 to $45.00 and set a “buy” rating on the stock in a research note on Monday, September 16th. JPMorgan Chase & Co. boosted their target price on Endava from $41.00 to $47.00 and gave the stock an “overweight” rating in a research report on Friday, September 6th. Susquehanna reduced their price target on Endava from $66.00 to $55.00 and set a “positive” rating for the company in a report on Friday, September 20th. Citigroup dropped their price objective on Endava from $30.00 to $27.00 and set a “neutral” rating on the stock in a report on Monday, October 28th. Finally, Needham & Company LLC reduced their target price on Endava from $42.00 to $33.00 and set a “buy” rating for the company in a report on Friday, September 20th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $41.71.
Read Our Latest Stock Report on Endava
About Endava
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Further Reading
- Five stocks we like better than Endava
- ETF Screener: Uses and Step-by-Step Guide
- Intel: Is Now the Time to Be Brave?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to buy stock: A step-by-step guide for beginners
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.